Intellipharmaceutics International Inc. (OTCMKTS:IPCIF – Get Free Report) (TSE:I) crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.06 and traded as high as $0.11. Intellipharmaceutics International shares last traded at $0.07, with a volume of 4,160 shares changing hands.
Intellipharmaceutics International Price Performance
The stock has a fifty day moving average price of $0.06 and a 200 day moving average price of $0.06.
Intellipharmaceutics International Company Profile
Intellipharmaceutics International Inc, a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States. It develops various drug delivery systems, product candidates, and a pipeline of products based on its patented Hypermatrix technology in various therapeutic areas, including neurology, cardiovascular, gastrointestinal tract, diabetes, and pain.
See Also
- Five stocks we like better than Intellipharmaceutics International
- 3 Warren Buffett Stocks to Buy Now
- MarketBeat Week in Review – 4/15 – 4/19
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Comprehensive Analysis of PayPal Stock
- What Makes a Stock a Good Dividend Stock?
- Intuitive Surgical Stock Can Trend Much Higher This Year
Receive News & Ratings for Intellipharmaceutics International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intellipharmaceutics International and related companies with MarketBeat.com's FREE daily email newsletter.